Citadel Advisors’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
|
|||||
2024
Q1 | $88.5K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $13.4K | Sell |
|
|||||
2022
Q3 | $10K | Buy |
|
|||||
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $67K | Sell |
|
|||||
2021
Q4 | $560K | Buy |
|
|||||
2021
Q3 | $325K | Buy |
|
|||||
2021
Q2 | $365K | Sell |
|
|||||
2021
Q1 | $802K | Buy |
|
|||||
2020
Q4 | $83K | Sell |
|
|||||
2020
Q3 | $187K | Buy |
|
|||||
2020
Q2 | $65K | Buy |
|
|||||
2020
Q1 | $45K | Sell |
|
|||||
2019
Q4 | $103K | Buy |
|
|||||
2019
Q3 | $25K | Sell |
|
|||||
2019
Q2 | $74K | Buy |
|
|||||
2019
Q1 | $17K | Sell |
|
|||||
2018
Q4 | $59K | Buy |
|
|||||
2018
Q3 | $38K | Sell |
|
|||||
2018
Q2 | $89K | Buy |
|
|||||
2018
Q1 | – | Sell |
|
|||||
2017
Q4 | $12K | Sell |
|
|||||
2017
Q3 | $36K | Buy |
|
|||||
2017
Q2 | – | Sell |
|
|||||
2017
Q1 | $65K | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $31K | Buy |
|